Commercializing viral vectors for gene therapies requires careful consideration of regulatory compliance, design, specifications, and supply chain strategies. It is imperative to understand and mitigate the key challenges of this journey to ensure timely and cost-effective delivery.
This webinar will take you through the development and commercialization of viral vectors for gene therapy, so you can navigate these hurdles and deliver the project in a timely, cost-effective manner. With integrated gene therapy development and manufacturing, you can benefit more than a customized solution. It improves coordination, streamlines decision-making, and uses resources more efficiently.